Treatment of persistent coronavirus disease 2019 (COVID-19) in a B cell acute lymphoblastic leukemia patient with using nirmatrelvir/ritonavir extended course: A case report
oleh: Hassan Almarhabi, Aisha Alharbi, Mai Alalawi, Mohamed Firoze Ahamed, Ihab El-Hemaidi, Nader Damfu
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2024-10-01 |
Deskripsi
Patients with hematological malignancies are at increased risk of persistent coronavirus disease 2019 (COVID-19) infection, a unique clinical condition, for which the optimal treatment is unknown. Here we report a case of persistent COVID-19 in acute lymphoblastic leukemia (ALL) patient who successfully responded to extended course nirmatrelvir/ritonavir.